Radiopharm Theranostics RADX
NASDAQ RADX
$1.44 -0.18 (-11.11%)
As of: Oct 1, 2026 · 10:36 AM EDT

Radiopharm Theranostics (RADX) Interest Coverage Ratio (2023 - 2026)

Updated

Radiopharm Theranostics' (RADX) Interest Coverage Ratio came in at -505.21 for FY2026 (year ended Jun 30, 2026), compared with -584.59 in FY2025.

Analysis

Radiopharm Theranostics (RADX) Interest Coverage Ratio (2023 - 2026) Analysis & Trends

Since FY2023, Radiopharm Theranostics has reported Interest Coverage Ratio for 4 fiscal years.

  • Annual Interest Coverage Ratio has run from a low of -584.59 in FY2025 to a high of -73.43 in FY2024 over five years.
  • Business Quant data shows RADX's Interest Coverage Ratio at -584.59 in FY2025, -73.43 in FY2024 and -400.59 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86 -505.21
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -505.21
Jun 30, 2025 -584.59
Jun 30, 2024 -73.43
Jun 30, 2023 -400.59
API Access

Radiopharm Theranostics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=RADX&period=max&api_key=YOUR_API_KEY